Immuno
Card STAT!
TM RSV (Meridian Bioscience, Inc, USA) is a rapid immunoassay method newly developed for detection of respiratory syncytial virus (RSV) by immunochromatography. We carried out an evaluation of the Immuno
Card STAT!
TM RSV.
One hundred fifty-nine nasal wash samples and nasopharyngeal aspirates from patients were used to evaluate three different kits, which are Immuno
Card STAT!
TM RSV, RSV testpack (Abbott JAPAN) and Directigen
TM EZ RSV (Nippon Becton, Dickinson and Company). One hundred twentyeight samples showed equivalent results.
When nested reversed transcription-PCR (nested RT-PCR) results for 31 samples showing discrepancies among three kits, 10 samples were positive, and 21 samples were negative by nested RTPCR. Compared to Nested RT-PCR results, Immuno
Card STAT!
TM RSV showed a sensitivity of 90.5% (19/21) and a specificity of 80.0% (8/10), as well as RSV testpack showed a sensitivity of 10.0% (2/21) and a specificity of 100% (10/10), Directigen
TM EZ RSV showed 95.2% (20/21) and 0.0% (0/10), respectively.
Furthermore, the detection limits were also evaluated by using ACTT No. VR1540 for RSV A-2 strain, and ACTT No. VR1401 for Wash strain.
The detection limit of Immuno
Card STAT!
TM RSV was 5.15×10
6 TCID
50/mL in subgroup A strain and was 7.58×10
5 TCID
50/mL in subgroup B strain. This result was similar to RSV testpack, and was better than the detection limit of Directigen EZ RSV.
It is concluded that Immuno
Card STAT!
TM RSV is useful in detecting RSV in a clinical setting with equivalent performance to conventional other detecting kits.
View full abstract